Organogenesis Holdings Inc. Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St rises on AI gains as oil slides, Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips briefly below $100 on Saudi exports, hopes of US-Iran diplomacy
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
Organogenesis Holding (ORGO) Misses Q1 EPS by 6c, Revenues Beat; Offers FY19 Revenue Outlook
May 10, 2019 7:16 AM EDTOrganogenesis Holding (NASDAQ: ORGO) reported Q1 EPS of ($0.17), $0.06 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $57.1 million versus the consensus estimate of $52.6 million.
First Quarter 2019 Financial Summary:
Net revenue of $57.1 million for the first quarter of 2019, up 60.8% compared to net revenue of $35.5 million for the first quarter of 2018. Net revenue comprised:Net revenue from Advanced Wound Care products of $47.8 million, up 63.7% from the first quarter of 2018.Net revenue from Surgical & Sports Medicine products of $9.3 million, up 47.2% from the first quarter of... More